European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - west nile recombinant canarypox virus (vcp2017 virus) - immunologicals for equidae, horse, immunologicals - horses - active immunisation of horses from five months of age against west nile disease by reducing the number of viraemic horses. if clinical signs are present, their duration and severity are reduced.

European Union - English - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - bempedoic acid - hypercholesterolemia; dyslipidemias - lipid modifying agents - nilemdo is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl c goals with the maximum tolerated dose of a statin (see sections 4.2, 4.3, and 4.4) or,alone or in combination with other lipid-lowering therapies in patients who are statin intolerant, or for whom a statin is contraindicated.